Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06644482
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-09
Brief Title:
Exercise As Treatment for Patients with Inclusion Body Myositis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exercise As Treatment for Patients with Inclusion Body Myositis
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There is little knowledge about exercise for patients with inclusion body myositis IBM Patients with IBM have limited access to rehabilitation and physiotherapy resources despite a significant need for these services due to the progressive nature of the condition which leads to a gradual decline in physical function The purpose of the project is to develop and implement a 16-week exercise intervention at Oslo University Hospital OUS for patients with IBM living in Oslo and the surrounding area The exercise sessions will take place once a week at OUS under the guidance of physiotherapists with extensive clinical experience with this patient group Patients are encouraged to exercise at home at least once a week between sessions at OUS to achieve sufficient amount of exercise that normally will improve physical fitness The feasibility and benefits of the exercise intervention will be evaluated using various methods such as focus group interviews physical tests and questionnaires The study will also provide valuable insight into whether exercise can lead to improvements in muscle strength fitness and balance in patients with IBM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None